Sunday, March 15, 2026 2:47 AM ET
15 hours ago
Older women set to inherit most of $54 trillion in 'great wealth transfer' to widowed spouses15 hours ago
FCC chair slams broadcasters after Trump disputes reports on Iran-damaged U.S. tankers7 hours ago
Elon Musk says xAI must be 'rebuilt' as co-founder exodus continues, SpaceX IPO awaits1 day ago
Iran threatens to retaliate against neighbors; Trump urges countries to assist in securing Strait of Hormuz7 hours ago
Vertex passes key test in quest to treat kidney diseases4 days ago
FDA approves leucovorin as first drug for rare genetic disorder4 days ago
Hims & Hers shares surge after Novo Nordisk drops patent infringement case4 days ago
Inside the booming business of wellness third spaces and membership clubs7 days ago
FDA vaccine head will step down in April after string of controversial decisions8 days ago
FDA reversals leave investors worrying about the fates of other experimental drugs8 days ago
FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's8 days ago
We're dipping into our large cash pile to buy more of this health-care stock9 days ago
Eli Lilly launches program to boost employer coverage of obesity drugs in U.S.9 days ago
Decades into cystic fibrosis fight, Boomer Esiason and son Gunnar are winning9 days ago
We've been active with trades during the Iran war fallout. Cramer explains our approach10 days ago
Here's Jim Cramer's advice for navigating the markets during the Iran conflict12 days ago
Why Novo Nordisk's Ireland expansion is key to fighting off Eli Lilly12 days ago
How the 'K-shaped' economy is showing up at two big U.S. gyms14 days ago
A rapid-fire update on our 4th Industrial Revolution stocks and our other names14 days ago
We're adding a stock to our Bullpen that is resistant to recessions, AI disruption15 days ago
Trump angering MAHA with glyphosate order gives Democrats an opening15 days ago
Novartis, Genentech file suit alleging illegal importation of prescription drug16 days ago
Healthy Returns: What's next for Novo Nordisk's next obesity drug CagriSema16 days ago
Novo Nordisk to slash Wegovy, Ozempic U.S. list prices by up to 50%18 days ago
Eli Lilly launches new form of Zepbound with a month of doses in one pen18 days ago
Novo Nordisk down 15% after weight loss drug fails to match Eli Lilly's in trial19 days ago
Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China23 days ago
Kennedy defends Trump glyphosate order as MAHA erupts23 days ago
FDA chief calls for reforms as U.S. loses ground to China in early drug trials23 days ago
FDA agrees to review Moderna's mRNA flu vaccine application in a reversal24 days ago
FDA chief Marty Makary says more drugs should be available over the counter24 days ago
Danaher is tapping the M&A well yet again. But we might have had enough25 days ago
French prosecutors investigate Nestle, Danone over contaminated baby formula25 days ago
Novo Nordisk faces a defining year in the obesity drug market26 days ago
How largest health-care education company in U.S. is tackling growing jobs gap1 month ago
Novo CEO sees 15 million patient opportunity in Medicare obesity coverage1 month ago